These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31881123)
1. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Chen Z; Wang Y; Fang M Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer. Chen ZQ; Huang LS; Zhu B Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803 [TBL] [Abstract][Full Text] [Related]
3. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion. Ai L; Wang W; Li J; Ye T; Li Y Am J Med Sci; 2024 Aug; 368(2):136-142. PubMed ID: 38583522 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study. Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016 [No Abstract] [Full Text] [Related]
5. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion. Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490 [TBL] [Abstract][Full Text] [Related]
6. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion]. Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS; Cheng BC; Ge W; Gao JF Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy. Bozkurt M; Yumru AE; Aral I Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047 [TBL] [Abstract][Full Text] [Related]
11. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
12. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. Wang XF; Wu YH; Wang MS; Wang YS Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057 [TBL] [Abstract][Full Text] [Related]
13. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion. Santotoribio JD; Del Valle-Vazquez L; García-de la Torre A; Del Castillo-Otero D; Lopez-Saez JB; Sanchez Del Pino MJ PLoS One; 2019; 14(9):e0222616. PubMed ID: 31550262 [TBL] [Abstract][Full Text] [Related]
15. P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma. Chen XK; Gu CL; Fan JQ; Zhang XM Biomed Pharmacother; 2020 May; 125():109871. PubMed ID: 32187953 [TBL] [Abstract][Full Text] [Related]
16. The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model. Wang J; Zhou J; Wu H; Chen Y; Liang B Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835879 [TBL] [Abstract][Full Text] [Related]
17. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491 [TBL] [Abstract][Full Text] [Related]
18. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading. Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060 [TBL] [Abstract][Full Text] [Related]
19. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis]. Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426 [TBL] [Abstract][Full Text] [Related]
20. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]